TrialMolecular autism2020

Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.

Dorinde M van Andel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.